venBio Partners LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1776382
SAN FRANCISCO, CA
Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,192,583
+$3,490,260 QoQ
Shares Held
472,194
-3.5% QoQ
Ownership
0.811%
of shares outstanding
% of Portfolio
3.31%
of 13F equity value
Holder Rank
#22
of 319 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026venBio Partners LLC holds $519,380,252 across 7 Biotechnology names. HRMY ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
|
4,643,430 | $160,569,809 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
5,266,697 | $144,149,496 | |
| 3 | ALMS |
Alumis Inc.
|
4,528,408 | $127,429,401 | |
| 4 | ACHV |
Achieve Life Sciences, Inc.
|
5,914,720 | $38,623,121 | |
| 5 | ALXO |
Alx Oncology Holdings Inc
|
12,884,638 | $26,671,200 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
472,194 | $17,192,583 | |
| 7 | LYEL |
Lyell Immunopharma, Inc.
|
337,697 | $4,744,642 |
All Filings in HRMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,192,583 | 472,194 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $13,702,323 | 489,194 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,305,639 | 489,194 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,482,186 | 489,194 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,458,530 | 489,194 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,236,348 | 489,194 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,553,665 | 539,194 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,583,760 | 614,594 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,237,897 | 1,035,396 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $34,768,597 | 1,035,396 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $33,443,290 | 1,035,396 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $33,929,926 | 1,035,396 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $36,435,585 | 1,035,396 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $33,805,679 | 1,035,396 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $57,050,319 | 1,035,396 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $49,856,057 | 1,125,673 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $70,654,074 | 1,448,720 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $75,139,146 | 1,544,484 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $116,851,125 | 2,740,411 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $117,412,226 | 3,063,194 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $98,935,535 | 3,504,624 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $115,792,776 | 3,504,624 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $126,692,157 | 3,504,624 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $118,806,753 | 3,504,624 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||